DSpace Repository

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis

Show simple item record

APA

Sereno, María & Jimenez Gordo, Ana María & Baena Espinar, Javier & Aguado, Carlos & Mielgo, Xabier & Pertejo, Ana & Álvarez Álvarez, Rosa & Sánchez, Ana & López, Jose Luis & Molina, Raquel & López Alfonso, Ana & Hernández, Berta & Enrique Chiara, Luis & Martín, Ana Manuela & López Martín, Ana & Dorta, Miriam & Collazo Lorduy, Ana & Casado, Enrique & Ramirez de Molina, Ana & Colmenarejo, Gonzalo (2021-08 ) .A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.

ISO 690

Sereno, María & Jimenez Gordo, Ana María & Baena Espinar, Javier & Aguado, Carlos & Mielgo, Xabier & Pertejo, Ana & Álvarez Álvarez, Rosa & Sánchez, Ana & López, Jose Luis & Molina, Raquel & López Alfonso, Ana & Hernández, Berta & Enrique Chiara, Luis & Martín, Ana Manuela & López Martín, Ana & Dorta, Miriam & Collazo Lorduy, Ana & Casado, Enrique & Ramirez de Molina, Ana & Colmenarejo, Gonzalo. 2021-08 .A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.

https://hdl.handle.net/20.500.12080/39499
dc.contributor.author Sereno, María
dc.contributor.author Jimenez Gordo, Ana María
dc.contributor.author Baena Espinar, Javier
dc.contributor.author Aguado, Carlos
dc.contributor.author Mielgo, Xabier
dc.contributor.author Pertejo, Ana
dc.contributor.author Álvarez Álvarez, Rosa
dc.contributor.author Sánchez, Ana
dc.contributor.author López, Jose Luis
dc.contributor.author Molina, Raquel
dc.contributor.author López Alfonso, Ana
dc.contributor.author Hernández, Berta
dc.contributor.author Enrique Chiara, Luis
dc.contributor.author Martín, Ana Manuela
dc.contributor.author López Martín, Ana
dc.contributor.author Dorta, Miriam
dc.contributor.author Collazo Lorduy, Ana
dc.contributor.author Casado, Enrique
dc.contributor.author Ramirez de Molina, Ana
dc.contributor.author Colmenarejo, Gonzalo
dc.date.accessioned 2024-02-05T09:20:39Z
dc.date.available 2024-02-05T09:20:39Z
dc.date.created 2021-08
dc.date.issued 2021-08
dc.identifier.uri https://hdl.handle.net/20.500.12080/39499
dc.description.abstract Infections with COVID-19 in neutropenic cancer patients are related to poor outcomes. A G-CSF treatment used in neutropenic cancer with SARS-CoV-2 infections is related to a higher rate of respiratory failure according to progressive and growing evidence. In this small retrospective non-randomized study, we found an association between G-CSF treatment and the parameters predisposing for worse infections with COVID-19 and neutropenia compared with patients not treated with G-CSF. We also found that the number of days on G-CSF treatment was related to a higher risk of mortality in a multivariable analysis among patients treated with G-CSF. es_ES
dc.format application/pdf es_ES
dc.language eng es_ES
dc.rights CC-BY es_ES
dc.rights.uri http://creativecommons.org/licenses/by/4.0/deed.es es_ES
dc.title A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.rights.accessrights info:eu-repo/semantics/openAccess es_ES
dc.identifier.location N/A es_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

CC-BY Except where otherwise noted, this item's license is described as CC-BY

Search DSpace


Browse

My Account

Social Media